Literature DB >> 3046608

Release of copper from yeast copper-thionein after S-alkylation of copper-thiolate clusters.

K Felix1, U Weser.   

Abstract

Our knowledge on the release of copper from Cu-thionein in biological systems is limited. Other than oxidative cleavage or direct transfer, the possibility of an alkylation mechanism seemed attractive. Iodoacetamide and methyl methanesulphonate were successfully employed to alkylate the Cu-thiolate sulphur atom of homogeneous Cu(I)-thionein from yeast. The alkylation caused a weakening of the Cu-S bonding, which led to the release of copper. After equilibrium dialysis a proportion of the released copper was found in the dialysis buffer. When iodoacetamide was used carboxymethylcysteine was detected in the protein hydrolysate. A 10-fold molar excess over cysteine was sufficient for complete alkylation, which could be conveniently monitored by c.d. at 328 and 359 nm. The reaction proceeded under both aerobic and anaerobic conditions. E.p.r. measurements of Cu2+ revealed unequivocally the complete cleavage of the Cu-thiolate bonding in less than 5 h. It is possible that this mode of copper release might be of relevance to the molecular transport of this biochemically important transition metal.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3046608      PMCID: PMC1149182          DOI: 10.1042/bj2520577

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  The role of Cu(I)-thiolate clusters during the proteolysis of Cu-thionein.

Authors:  U Weser; W Mutter; H J Hartmann
Journal:  FEBS Lett       Date:  1986-03-03       Impact factor: 4.124

2.  Oxidation of Cu(I)-thionein by enzymically generated H2O2.

Authors:  H J Hartmann; A Gärtner; U Weser
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1984-11

3.  Copper transport from Cu(I)-thionein into apo-caeruloplasmin mediated by activated leucocytes.

Authors:  T Schechinger; H J Hartmann; U Weser
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

4.  Yeast metallothionein. Sequence and metal-binding properties.

Authors:  D R Winge; K B Nielson; W R Gray; D H Hamer
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

5.  Differently bound copper(I) in yeast Cu8-thionein.

Authors:  U Weser; H J Hartmann
Journal:  Biochim Biophys Acta       Date:  1988-03-02

6.  Studies on the metabolism of rat liver copper-metallothionein.

Authors:  R K Mehra; I Bremner
Journal:  Biochem J       Date:  1985-05-01       Impact factor: 3.857

7.  Reconstitution of stellacyanin as a case of direct Cu(I) transfer between yeast copper thionein and 'blue' copper apoprotein.

Authors:  H J Hartmann; L Morpurgo; A Desideri; G Rotilio; U Weser
Journal:  FEBS Lett       Date:  1983-02-07       Impact factor: 4.124

8.  Cadmium binding and metal cluster formation in metallothionein: a differential modification study.

Authors:  W R Bernhard; M Vasák; J H Kägi
Journal:  Biochemistry       Date:  1986-04-22       Impact factor: 3.162

9.  Copper dependent control of the enzymic and phagocyte induced degradation of some biopolymers, a possible link to systemic inflammation.

Authors:  H J Hartmann; A Gärtner; U Weser
Journal:  Clin Chim Acta       Date:  1985-10-31       Impact factor: 3.786

10.  Yeast copper-thionein can reconstitute the Japanese-lacquer-tree (Rhus vernicifera) laccase from the Type 2-copper-depleted enzyme via a direct copper(I)-transfer mechanism.

Authors:  L Morpurgo; H J Hartmann; A Desideri; U Weser; G Rotilio
Journal:  Biochem J       Date:  1983-05-01       Impact factor: 3.857

View more
  4 in total

1.  Cu(I)-thionein release from copper-loaded yeast cells.

Authors:  K Felix; H J Hartmann; U Weser
Journal:  Biol Met       Date:  1989

2.  Copper-release from yeast Cu(I)-thionein by hypothiocyanite (OSCN-).

Authors:  H J Hartmann; D Deters; U Weser
Journal:  Biometals       Date:  1996-10       Impact factor: 2.949

3.  Experimental basis for increasing the therapeutic index of cis-diamminedicarboxylatocyclobutaneplatinum(II) in brain tumor therapy by a high-zinc diet.

Authors:  F Doz; M E Berens; C F Deschepper; D V Dougherty; V Bigornia; M Barker; M L Rosenblum
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 4.  Metallothionein and anticancer agents: the role of metallothionein in cancer chemotherapy.

Authors:  F Doz; N Roosen; M L Rosenblum
Journal:  J Neurooncol       Date:  1993-08       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.